ARUK: Towards a Cure marks a pivotal moment both for everyone affected by dementia and for us as a charity.

Dementia is the UK’s biggest killer and 1 in 2 of us will be directly affected by it. For many years, the situation has felt hopeless – but global optimism around new treatments and host of advances in research are now revealing a path to a cure.

We are at the beginning of our journey – but with the right support and action, it’s a matter of when, not if, life-changing treatments arrive.  Our new strategy sets out our path towards a cure. We are grateful to our supporters and people directly affected by dementia, whose feedback has shaped the strategy.

Our vision is a world free from the fear, harm and heartbreak of dementia

Our mission is to accelerate progress towards a cure

Our strategy to 2033

Our goals

Our goals describe the changes we want to see for people affected by dementia in the next 10 years.


People will be able to access new life changing treatments for the diseases that cause dementia.


People will get an earlier and more accurate diagnosis of the diseases that cause dementia, for improved access to research and treatments.


Fewer people will develop the diseases that cause dementia.

Our enablers

Our enablers describe the changes we’ll make as an organisation with the help of our supporters.


We'll make progress with the dedication and generosity of every supporter.


We'll generate awareness, impact and action.


We'll develop our people, systems and structures.

Find out more

Download the full ARUK: Towards a Cure strategy to read more detail about each goal.

Our 10-year strategy

Alzheimer's Research UK: Towards a Cure defines the change we want to see for people affected by dementia. And identifies the unique role that we play.

MicrosoftTeams-image (3) (1)

"I’m delighted to have given my views in the development of ARUK: Towards a Cure. While sadly progress will be too late for Frank, I am full of hope and optimism that people diagnosed with dementia will in the future have more options to live longer, better lives."

- Alison Littleford, Alzheimer's Research UK Patient Representative


Leave a Comment